Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Aminopterin in Treating Patients With Refractory Leukemia

NCT00003305

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Advanced Urology Medical Center Anaheim, California, United States
  • South Coast Urological Medical Group Laguana Hills, California, United States
  • Urology Specialists, P.C. Waterbury, Connecticut, United States
  • Barzell, Whitmore, Treiman and Dunne - The Urology Treatment Center Sarasota, Florida, United States
View all 14 locations
View Trial Details
Completed

Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma

NCT00656812

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Universitätsklinikum Graz Graz, Austria
  • Universitaetsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria
  • Krankenhaus der Stadt Linz Linz, Austria
  • Universitaetsklinik f. Innere Medizin III Salzburg, Austria
View Trial Details
Completed

Lymphoma Follow-up

NCT00744120

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • NIA Clinical Research Unit Baltimore, Maryland, United States
View Trial Details
Completed

Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

NCT00071955

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Rush Cancer Institute at Rush University Medical Center Chicago, Illinois, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details

Related conditions